Research Article
Synovial Sarcoma of the Head and Neck: A Single Institution Review
Table 1
Patient characteristics.
| | Variable | (%) |
| | Total cohort | 44 (100) | | Median age at diagnosis, years | 31.5 | | Sex | | | Male | 34 (77) | | Female | 10 (23) | | Total | 44 | | Race | | | White | 33 (75) | | Other | 11 (25) | | Total | 44 | | Tumor size | | | ≥5 cm | 20 (53) | | <5 cm | 18 (47) | | Total | 38 | | Subtype | | | Monophasic | 19 (58) | | Biphasic | 12 (36) | | Poorly differentiated | 2 (6) | | Total | 33 | | Surgical margin | | | Positive | 6 (30) | | Negative | 14 (70) | | Total | 20 | | Fusion gene (SS18-SSX) | | | Present | 19 (43.2) | | Not tested | 26 (59.1) | | Total | 44 | | Site | | | Face | 8 (18) | | Pharynx/larynx | 12 (27) | | Neck | 15 (34) | | Oral cavity | 5 (11) | | Other | 4 (9) | | Total | 44 | | Treatment | | | Definitive local therapy | 15 (37) | | Local + systemic therapy | 25 (61) | | Systemic therapy only | 1 (2) | | Total | 41 |
|
|